| INFARMED [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Neurological
> Multiple sclerosis | Regulatory partnership
> Working with regulatory bodies | 1,000 | National | Regularly | 115015053859 |
| We are partners in the Projeto Incluir [Inclusion Project] led by Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Cancer
> Cancer: breast | Regulatory partnership
> Working with regulatory bodies | 1,000 | Regional | Regularly | 115017018417 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Hearing Loss
> Hearing loss | Regulatory partnership
> Working with regulatory bodies | 100 | National | No | 115029020137 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascular
> Stroke | Regulatory partnership
> Working with regulatory bodies | 5,000 | National | Regularly | 115032426383 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Patient advocacy
> Patient advocacy | Regulatory partnership
> Working with regulatory bodies | 5,000 | National | Rarely | 115033491291 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Mental health
> Mental health: most conditions | Regulatory partnership
> Working with regulatory bodies | 10,000 | National | Regularly | 115056273634 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Patient advocacy
> Patient advocacy | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 5,000 | National | Rarely | 115033491291 |
| We occasionally receive a form through which we are invited to submit written contributions to HTA [Avaliação de Tecnologias de Saúde – Health Technology Assessment] processes. | Rheumatic
> Rheumatic diseases: most types | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 100 | National | Sometimes | 115060632863 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurological
> Multiple sclerosis | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 5,000 | National | Regularly | 115060898897 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Patient advocacy
> Patient advocacy | Regulatory partnership
> Contribute to Marketing Authorisation submissions | 5,000 | National | Rarely | 115033491291 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Hearing Loss
> Hearing loss | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 100 | National | No | 115029020137 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Patient advocacy
> Patient advocacy | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 5,000 | National | Rarely | 115033491291 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurological
> Multiple sclerosis | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 5,000 | National | Regularly | 115060898897 |
| Negotiation with the government or with parliamentary groups. | General health
> Obesity | Impacting policy and legislation
> Influence healthcare policy and legislation | 1,000 | National | Regularly | 115006675660 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratory
> Asthma | Impacting policy and legislation
> Participate in public hearings and consultations | Do not know | National | Sometimes | 115032964525 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratory
> Asthma | Impacting policy and legislation
> Participate in public hearings and consultations | Do not know | National | Sometimes | 115032964525 |
| 2023: meeting with the Parliamentary Health Group at the AR [Assembleia da República – Assembly of the Republic]. | Cardiovascular
> Cardiovascular & heart conditions | Impacting policy and legislation
> Participate in public hearings and consultations | 1,000 | National | Sometimes | 115054128784 |
| Negotiation with the government or with parliamentary groups. | General health
> Obesity | Impacting policy and legislation
> Mobilise parliamentarians and political leaders | 1,000 | National | Regularly | 115006675660 |
| Each year, we submit our advocacy document to the parliamentary groups. | Disability
> Disability: most types | Impacting policy and legislation
> Mobilise parliamentarians and political leaders | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Through the Parliamentary Health Group. | Cardiovascular
> Cardiovascular & heart conditions | Impacting policy and legislation
> Mobilise parliamentarians and political leaders | 100 | National | Regularly | 115033109950 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Disability
> Disability: most types | Pricing and affordability advocacy
> Advocate for fair medicine pricing | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Disability
> Disability: most types | Pricing and affordability advocacy
> Address cost barriers for low-income and vulnerable people | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Active participation in discussions on access to PAP [Programas de Acesso Precoce – Early Access Programmes] and in the centralised funding of medicines intended for rare diseases. | Neuromuscular
> Neuromuscular diseases: most types | Improving access pathways
> Improving access to rare/ultra-rare therapies | 1,000 | National | Regularly | 115022855373 |
| Questionnaire for the collection of contributions from patient associations in the context of Health Technology Assessment [in Portugal]. | Gastrointestinal
> Gastrointestinal: other | Evidence-based patient input
> Conduct surveys/research to generate data | 1,000 | National | Sometimes | 114997613546 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratory
> Asthma | Evidence-based patient input
> Conduct surveys/research to generate data | Do not know | National | Sometimes | 115032964525 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascular
> Stroke | Institutional governance
> Ensure representation within governmental advisory bodies | 5,000 | National | Regularly | 115032426383 |
| Projeto Incluir [The project establishes a formal mechanism for patient rights and civic participation in Portugal. It allows patients and their advocacy organizations to have an active voice in Health Technology Assessment (HTA), Medicine Shortages & Safety and Policy Representation: Acting as a bridge between policymakers and citizens, ensuring that healthcare decisions account for patient values and experiences.] | Patient advocacy
> Patient rights | Institutional governance
> Ensure representation within governmental advisory bodies | 5,000 | National | Regularly | 115042989304 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Mental health
> Mental health: most conditions | Institutional governance
> Ensure representation within governmental advisory bodies | 10,000 | National | Regularly | 115056273634 |
| Through the Parliamentary Health Group. | Cardiovascular
> Cardiovascular & heart conditions | Institutional governance
> Working effectively within multi-stakeholder networks | 100 | National | Regularly | 115033109950 |
interactions
actions & advocacy
13 mentions
